Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Change in Receivables (2023 - 2025)

Cannabis Bioscience International Holdings' Change in Receivables history spans 3 years, with the latest figure at $12845.0 for Q4 2025.

  • For Q4 2025, Change in Receivables rose 482.63% year-over-year to $12845.0; the TTM value through Nov 2025 reached $7992.0, up 260.29%, while the annual FY2025 figure was -$13759.0, 235.05% down from the prior year.
  • Change in Receivables for Q4 2025 was $12845.0 at Cannabis Bioscience International Holdings, up from $2586.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $17444.0 in Q3 2023 and bottomed at -$28765.0 in Q1 2023.
  • The 3-year median for Change in Receivables is $411.5 (2024), against an average of -$903.33.
  • The largest YoY upside for Change in Receivables was 482.63% in 2025 against a maximum downside of 534.09% in 2025.
  • A 3-year view of Change in Receivables shows it stood at -$8590.0 in 2023, then surged by 60.92% to -$3357.0 in 2024, then skyrocketed by 482.63% to $12845.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Change in Receivables are $12845.0 (Q4 2025), $2586.0 (Q3 2025), and $3740.0 (Q2 2025).